Association between clinical disease activity and Epstein–Barr virus reactivation in MS

Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA Polymerase

1988 • 17,059 citations

Rating neurologic impairment in multiple sclerosis

1983 • 14,011 citations

New diagnostic criteria for multiple sclerosis: Guidelines for research protocols

1983 • 7,404 citations

Rapid and simple method for purification of nucleic acids

1990 • 5,273 citations

Defining the clinical course of multiple sclerosis

1996 • 3,606 citations

Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein

1995 • 1,528 citations

Amino Acid Homology Between the Encephalitogenic Site of Myelin Basic Protein and Virus: Mechanism for Autoimmunity

1985 • 941 citations

Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis

1997 • 477 citations

Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions.

1995 • 473 citations

Association of human herpes virus 6 (HHV-6) with multiple sclerosis: Increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA

1997 • 446 citations

Multiple sclerosis: In situ evidence for antibody‐ and complement‐mediated demyelination

1998 • 423 citations

YELLOW NAILS AND LYMPHOEDEMA.

1964 • 370 citations

Tumor necrosis factor‐α messenger RNA expression in patients with relapsing‐remitting multiple sclerosis is associated with disease activity

1995 • 336 citations

Identification of High Potency Microbial and Self Ligands for a Human Autoreactive Class II–restricted T Cell Clone

1997 • 320 citations

Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus

1995 • 262 citations

Effect of acyclovir [9-(2-hydroxyethoxymethyl)guanine] on Epstein-Barr virus DNA replication

1980 • 219 citations

Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection.

1987 • 202 citations

Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis

1998 • 178 citations

Epstein‐Barr nuclear antigen and viral capsid antigen antibody titers in multiple sclerosis

1985 • 130 citations

Epstein-Barr Virus Antibodies in Multiple Sclerosis

1980 • 123 citations

Increased prevalence and titer of Epstein‐Barr virus antibodies in patients with multiple sclerosis

1985 • 120 citations

EBV-induced expression and HLA-DR-restricted presentation by human B cells of alpha B-crystallin, a candidate autoantigen in multiple sclerosis.

1999 • 120 citations

Acyclovir treatment of relapsing-remitting multiple sclerosis

1996 • 120 citations

A case‐control study of multiple sclerosis

1989 • 116 citations

Absence of seven human herpesviruses, including HHV-6, by polymerase chain reaction in CSF and blood from patients with multiple sclerosis and optic neuritis

1997 • 105 citations

EBV-Induced Expression and HLA-DR-Restricted Presentation by Human B Cells of αB-Crystallin, a Candidate Autoantigen in Multiple Sclerosis

1999 • 103 citations

Antibodies against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis CSG and two pentapepfide seauence identities between EBNA A and myelin basic protein

1992 • 103 citations

Characterization of the 92,000-dalton glycoprotein induced by herpes simplex virus type 2

1984 • 97 citations

COINCIDENCE OF EPSTEIN-BARR VIRUS REACTIVATION, CYTOMEGALOVIRUS INFECTION, AND REJECTION EPISODES IN RENAL TRANSPLANT RECIPIENTS

1995 • 74 citations

Detection of immunoglobulin M antibodies to glycoprotein G-2 by western blot (immunoblot) for diagnosis of initial herpes simplex virus type 2 genital infections

1993 • 73 citations

Daily urinary neopterin excretion as an immunological marker of disease activity in multiple sclerosis

1997 • 72 citations

The significance of Epstein-Barr virus seropositivity in multiple sclerosis patients?

2009 • 57 citations

Evaluation of three commercial enzyme-linked immunosorbent assays and two latex agglutination assays for diagnosis of primary Epstein-Barr virus infection

1997 • 48 citations

A Putative New Retrovirus Associated with Multiple Sclerosis and the Possible Involvement of Epstein‐Barr Virus in This Disease^a

1994 • 41 citations

Serological diagnosis of infectious mononucleosis using three anti-Epstein-Barr virus recombinant ELISAs

1993 • 38 citations

Soluble HLA class I and class II antigens in patients with multiple sclerosis

1998 • 36 citations

Herpesvirus hominis antibody in multiple sclerosis and amyotrophic lateral sclerosis

1972 • 25 citations

Anti-Epstein-Barr Virus-Nuclear Antigen-1,-2A and-2B Antibodies in Rheumatoid Arthritis Patients and Their Relatives

1992 • 14 citations